(Pm-19) Insights Into The Pathophysiology Of Hypersexuality: A Comprehensive Literature Exploration

B O Ferreira,B J Teixeira,L Talib,M T Scanavino
DOI: https://doi.org/10.1093/jsxmed/qdae018.047
2024-03-29
The Journal of Sexual Medicine
Abstract:Introduction Hypersexuality or Compulsive Sexual Behavior Disorder (CSBD) is characterized by a spectrum of sexual behaviors and fantasies marked by compulsion, obsession, and impulsivity. The pathophysiology of CSBD remains poorly understood despite the arousing of articles exploring the potential biomarkers associated with hypersexuality. Objective We aimed to review the literature regarding the investigation on CSBD pathophysiology from a neuroimaging, neuroendocrine and molecular perspective. Methods We raised papers related on neuroimaging, neuroendocrine and molecular biomarkers investigated in individuals that reached diagnosis of CSBD or similar, written in English language in the last 10 years, through PubMed, Scopus, and Web of Science with biomarkers and compulsive sexual behavior/hypersexuality key terms. Results Neuroimaging studies revealed the activation of the anterior cingulate cortex, ventral striatum, and amygdala, in individuals with CSBD. Neuroendocrine markers revealed abnormalities in the hypothalamic-pituitary-adrenal (HPA) axis, including elevated adrenocorticotropic hormone (ACTH) levels and non-suppression of dexamethasone. Findings concerning the hypothalamic-pituitary-gonadal (HPG) axis, responsible for sexual function regulation, varied among CSBD individuals, including testosterone and luteinizing hormone (LH) levels. Oxytocin levels have been noted to rise in CSBD individuals and subsequently decrease following psychotherapy. Genetic and epigenetic markers associated with CSBD suggest involvement of addiction-related genes and epigenetic modifications near the corticotropin-releasing hormone (CRH) gene. Conclusion Most of the findings point to HPA axis alterations. Molecular analysis is in the beginning, as well as more research on the HPG axis is needed. The exploration of CSBD biomarkers potentially will provide insights into its pathophysiology, diagnosis, and treatment. Financing FAPESP.
urology & nephrology
What problem does this paper attempt to address?
This paper aims to explore the pathophysiological mechanisms of Compulsive Sexual Behavior Disorder (CSBD), also known as hypersexuality. Although numerous studies have investigated potential biomarkers associated with hypersexuality, its pathophysiological mechanisms remain unclear. To this end, the authors reviewed research literature from the past 10 years on neuroimaging, neuroendocrine, and molecular markers related to CSBD, and conducted a comprehensive analysis of findings in these areas. The research results indicate that in individuals with CSBD, brain regions such as the anterior cingulate cortex, ventral striatum, and amygdala show activation. Neuroendocrine abnormalities are primarily reflected in the hypothalamic-pituitary-adrenal (HPA) axis, characterized by elevated levels of adrenocorticotropic hormone (ACTH) and a lack of suppression in the dexamethasone suppression test. Regarding the hypothalamic-pituitary-gonadal (HPG) axis, which regulates sexual function, results vary among different patients, including changes in testosterone and luteinizing hormone (LH) levels. Additionally, oxytocin levels are elevated in CSBD patients and decrease after receiving psychological treatment. Genetic and epigenetic studies suggest that addiction-related genes and epigenetic modifications near the corticotropin-releasing hormone (CRH) gene may be involved in the development of CSBD. In summary, most research findings point to alterations in the HPA axis. However, molecular-level studies are still in their infancy, and more in-depth exploration of the HPG axis is needed. Future investigations into CSBD biomarkers are expected to provide important clues for understanding its pathophysiological mechanisms, diagnostic methods, and treatment strategies.